Treatment options in patients with bone metastases of differentiated thyroid carcinoma are limited and mostly aimed at palliation. Conventional treatment modalities are: radioiodine therapy, surgery or external irradiation. A lesser known option is selective embolization of tumour metastases. During selective catheterization of the arteries that feed the metastases embolization material (e.g. polyvinyl alcohol particles) is injected into the local vasculature under radiographic control. The embolization is immediately evaluated angiographically. This therapy was used in three patients with differentiated thyroid carcinoma, a 60-year-old man suffering from back ache, paresis and afterwards paralysis of the lower body parts with incontinence,...
embolisation with N-2-butyl-cyanoacrylate from 2004 to 2011. All patients had primary treatments inc...
BACKGROUND: The prognosis of patients with metastatic, recurrent, and/or unresectable osteosarcoma i...
Selective embolization for bone metastases with N-Butyl cyanoacrylate: 309 procedures in 7 year
Treatment options in patients with bone metastases of differentiated thyroid carcinoma are limited a...
Treatment options in patients with bone metastases of differentiated thyroid carcinoma are limited a...
BACKGROUND The outcome for patients with bone metastases from differentiated thyroid carcinoma is wo...
Background: Selective embolization therapy (SET) has been employed to treat a number of malignant tu...
Background: Selective embolization therapy (SET) has been employed to treat a number of malignant tu...
The authors present the experience of a single institution with selective arterial embolisation for ...
Treatment options in patients with bone metastases are mostly aimed at palliation. The goals of trea...
This study was done to evaluate embolisation for palliative and/or adjuvant treatment of bone metast...
Purpose: To evaluate the clinical and imaging effect of selective embolization using N-butyl cyanoac...
embolisation with N-2-butyl-cyanoacrylate from 2004 to 2011. All patients had primary treatments inc...
BACKGROUND: The prognosis of patients with metastatic, recurrent, and/or unresectable osteosarcoma i...
Selective embolization for bone metastases with N-Butyl cyanoacrylate: 309 procedures in 7 year
Treatment options in patients with bone metastases of differentiated thyroid carcinoma are limited a...
Treatment options in patients with bone metastases of differentiated thyroid carcinoma are limited a...
BACKGROUND The outcome for patients with bone metastases from differentiated thyroid carcinoma is wo...
Background: Selective embolization therapy (SET) has been employed to treat a number of malignant tu...
Background: Selective embolization therapy (SET) has been employed to treat a number of malignant tu...
The authors present the experience of a single institution with selective arterial embolisation for ...
Treatment options in patients with bone metastases are mostly aimed at palliation. The goals of trea...
This study was done to evaluate embolisation for palliative and/or adjuvant treatment of bone metast...
Purpose: To evaluate the clinical and imaging effect of selective embolization using N-butyl cyanoac...
embolisation with N-2-butyl-cyanoacrylate from 2004 to 2011. All patients had primary treatments inc...
BACKGROUND: The prognosis of patients with metastatic, recurrent, and/or unresectable osteosarcoma i...
Selective embolization for bone metastases with N-Butyl cyanoacrylate: 309 procedures in 7 year